Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Fondazione Centro San Raffaele is active in the Biotechnology & Pharmaceuticals technology area. The company currently has 1 pending office action. This action is assigned to 1 distinct examiner and is located within 1 distinct art unit. This indicates that the company's current patenting activity is focused on a single point of engagement at the USPTO.
The busiest examiner for this portfolio is TATGE, LEXUS MARC. This examiner is responsible for 1 pending office action. Since there is 1 pending action in total, this individual oversees the entire active workload. The prosecution strategy for the company is therefore dependent on the specific feedback and requirements of this one examiner.
The involvement of 1 distinct art unit suggests that the technical scope of the pending application is specific to a single classification. Practitioners should prepare for a consistent examination experience, as no other examiners or art units are currently involved. This creates a streamlined but singular prosecution path within the Biotechnology & Pharmaceuticals sector.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| TATGE, LEXUS MARC | 1 | 25.0% | +100.0% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18263668 | GUIDE RNAS AND USES THEREOF | TATGE, LEXUS MARC | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18263668 | GUIDE RNAS AND USES THEREOF | TATGE, LEXUS MARC | — |
| Art Unit | Apps |
|---|---|
| 1637 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18263668 | GUIDE RNAS AND USES THEREOF | TATGE, LEXUS MARC | 1637 | §102§112 | Non-Final OA | — | Pending | Jul 31, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialFondazione Centro San Raffaele has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Lexus Marc Tatge has the most, with 1 of Fondazione Centro San Raffaele's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
